Analysis of growth factor expression in affected and unaffected muscles of oculo-pharyngeal muscular dystrophy (OPMD) patients: A pilot study

Neuromuscular Disorders

Volumn 19, Issue 3, 2009, Pages 199-206

  Bouazza, Belaid ^a,b   Kratassiouk, Gueorgui ^c   Gjata, Bernard ^e   Perie, Sophie ^d   Guily, Jean Lacau St ^d   Butler Browne, Gillian S ^a,b   Svinartchouk, Fedor ^e  

^a SORBONNE UNIVERSITÉ   (France)

^b Sorbonne Université   (France)

^c INSTITUT ANDRÉ LWOFF   (France)

^d HÔPITAL TENON   (France)

^e GÉNÉTHON   (France)

Author keywords

Chemokines; Cytokines; Fibrosis; Growth factors; Oculo pharyngeal muscular dystrophy

Indexed keywords

AMPHIREGULIN; ANGIOGENIN; ANGIOPOIETIN 2; CHEMOKINE; CUTANEOUS T CELL ATTRACTING CHEMOKINE; CXCL11 CHEMOKINE; CYTOKINE; GROWTH FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 3; INTERLEUKIN 11; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 8; LYMPHOTACTIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; ONCOSTATIN M; OSTEOPROTEGERIN; PROTEIN PARC; RANTES; THROMBOPOIETIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN; VASCULOTROPIN D;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRICOPHARYNGEUS MUSCLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE BIOPSY; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STERNOCLEIDOMASTOID MUSCLE; UNINDEXED SEQUENCE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHEMOKINES; COMPUTATIONAL BIOLOGY; CYTOKINES; FEMALE; FIBROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, OCULOPHARYNGEAL; PILOT PROJECTS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SOFTWARE;

EID: 61849147416     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2008.12.003     Document Type: Article

References (33)

1. Duranceau A.C., Beauchamp G., Jamieson G.G., and Barbeau A. Oropharyngeal dysphagia and oculopharyngeal muscular dystrophy. Surg Clin North Am 63 (1983) 825-832
2. Blumen S.C., Nisipeanu P., Sadeh M., et al. Epidemiology and inheritance of oculopharyngeal muscular dystrophy in Israel. Neuromuscul Disord 7 Suppl. 1 (1997) S38-S40
3. Abu-Baker A., and Rouleau G.A. Oculopharyngeal muscular dystrophy: recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies. Biochim Biophys Acta 1772 (2007) 173-185
4. Becher M.W., Morrison L., Davis L.E., et al. Oculopharyngeal muscular dystrophy in Hispanic New Mexicans. JAMA 286 (2001) 2437-2440
5. Brais B., Bouchard J.P., Xie Y.G., et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet 18 (1998) 164-167
6. Tome F.M., and Fardeau M. Nuclear inclusions in oculopharyngeal dystrophy. Acta Neuropathol 49 (1980) 85-87
7. Uyama E., Uchino M., Chateau D., and Tome F.M. Autosomal recessive oculopharyngodistal myopathy in light of distal myopathy with rimmed vacuoles and oculopharyngeal muscular dystrophy. Neuromuscul Disord 8 (1998) 119-125
8. Uyama E., Nohira O., Chateau D., et al. Oculopharyngeal muscular dystrophy in two unrelated Japanese families. Neurology 46 (1996) 773-778
9. Munitiz V., Ortiz A., Martinez de Haro L.F., et al. Diagnosis and treatment of oculopharyngeal dystrophy: a report of three cases from the same family. Dis Esophagus 16 (2003) 160-164
10. Lacau St. Guily J., Zhang K.X., Perie S., et al. Improvement of dysphagia following cricopharyngeal myotomy in a group of elderly patients. Histochemical and biochemical assessment of the cricopharyngeal muscle. Ann Otol Rhinol Laryngol 104 (1995) 603-609
11. Cruse J.P., Edwards D.A., Smith J.F., and Wyllie J.H. The pathology of a cricopharyngeal dysphagia. Histopathology 3 (1979) 223-232
12. Tatsumi R., Liu X., Pulido A., et al. Satellite cell activation in stretched skeletal muscle and the role of nitric oxide and hepatocyte growth factor. Am J Physiol Cell Physiol 290 (2006) C1487-C1494
13. Sheehan S.M., Tatsumi R., Temm-Grove C.J., and Allen R.E. HGF is an autocrine growth factor for skeletal muscle satellite cells in vitro. Muscle Nerve 23 (2000) 239-245
14. Tatsumi R., Anderson J.E., Nevoret C.J., Halevy O., and Allen R.E. HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells. Dev Biol 194 (1998) 114-128
15. Fukushima K., Nakamura A., Ueda H., et al. Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ). BMC Musculoskelet Disord 8 (2007) 54
16. Dennis R.A., Przybyla B., Gurley C., et al. Aging alters gene expression of growth and remodeling factors in human skeletal muscle both at rest and in response to acute resistance exercise. Physiol Genomics 32 (2008) 393-400
17. Chin J.R., and Werb Z. Matrix metalloproteinases regulate morphogenesis, migration and remodeling of epithelium, tongue skeletal muscle and cartilage in the mandibular arch. Development 124 (1997) 1519-1530
18. Haslett J.N., and Kunkel L.M. Microarray analysis of normal and dystrophic skeletal muscle. Int J Dev Neurosci 20 (2002) 359-365
19. Ness S.A. Microarray analysis: basic strategies for successful experiments. Mol Biotechnol 36 (2007) 205-219
20. Reid J.D., Parker C.E., and Borchers C.H. Protein arrays for biomarker discovery. Curr Opin Mol Ther 9 (2007) 216-221
21. Sachdeva N., and Asthana D. Cytokine quantitation: technologies and applications. Front Biosci 12 (2007) 4682-4695
22. Ling M.M., Ricks C., and Lea P. Multiplexing molecular diagnostics and immunoassays using emerging microarray technologies. Expert Rev Mol Diagn 7 (2007) 87-98
23. Perie S., Mamchaoui K., Mouly V., et al. Premature proliferative arrest of cricopharyngeal myoblasts in oculo-pharyngeal muscular dystrophy: therapeutic perspectives of autologous myoblast transplantation. Neuromuscul Disord 16 (2006) 770-781
24. Ho C.Y., Stromer M.H., and Robson R.M. Identification of the 30 kDa polypeptide in post mortem skeletal muscle as a degradation product of troponin-T. Biochimie 76 (1994) 369-375
25. Watanabe N. Clinical significance of measurement of circulating tumor necrosis factor alpha. Rinsho Byori 49 (2001) 829-833
26. Saito A., Higuchi I., Nakagawa M., et al. An overexpression of fibroblast growth factor (FGF) and FGF receptor 4 in a severe clinical phenotype of facioscapulohumeral muscular dystrophy. Muscle Nerve 23 (2000) 490-497
27. Johansson A., Ahren B., Forsberg H., and Olsson T. Testosterone and diurnal rhythmicity of leptin, TNF-alpha and TNF-II receptor in insulin-resistant myotonic dystrophy patients. Int J Obes Relat Metab Disord 26 (2002) 1386-1392
28. Goding Jr. G.S., Al-Sharif K.I., and McLoon L.K. Myonuclear addition to uninjured laryngeal myofibers in adult rabbits. Ann Otol Rhinol Laryngol 114 (2005) 552-557
29. Wirtschafter J.D., Ferrington D.A., and McLoon L.K. Continuous remodeling of adult extraocular muscles as an explanation for selective craniofacial vulnerability in oculopharyngeal muscular dystrophy. J Neuroophthalmol 24 (2004) 62-67
30. Cittadini A., Ines Comi L., Longobardi S., et al. A preliminary randomized study of growth hormone administration in Becker and Duchenne muscular dystrophies. Eur Heart J 24 (2003) 664-672
31. Hinz B., Phan S.H., Thannickal V.J., et al. The myofibroblast: one function, multiple origins. Am J Pathol 170 (2007) 1807-1816
32. Safadi R., and Friedman S.L. Hepatic fibrosis - role of hepatic stellate cell activation. MedGenMed 4 (2002) 27
33. Bansal M.B., Kovalovich K., Gupta R., et al. Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis in mice by reducing MMP-2 expression. J Hepatol 42 (2005) 548-556